Clinical Trial: Use of Insulin Glargine to Treat Diabetic Ketoacidosis
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Early Use of Insulin Glargine in Diabetic Ketoacidosis
Brief Summary:
The purpose of this study is to determine the effects of the addition of insulin glargine during the early phase of moderate to severe Diabetic Ketoacidosis (DKA) in children.
The investigators hypothesize that the addition of insulin glargine during the early phase of management of DKA will accelerate acidosis correction, decrease the length of insulin infusion, and decrease the total intensive care unit time in children admitted to the ICU.
Detailed Summary:
Sponsor: Vanderbilt University
Current Primary Outcome: Time of acidosis correction [ Time Frame: Minutes ]
Original Primary Outcome:
Current Secondary Outcome:
- Time on insulin drip [ Time Frame: Minutes ]
- Total hospital stay [ Time Frame: Days ]
Original Secondary Outcome:
Information By: Vanderbilt University
Dates:
Date Received: September 13, 2005
Date Started: August 2004
Date Completion: September 2012
Last Updated: June 20, 2012
Last Verified: June 2012
